Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Myocardial Reperfusion Injury 2Cardiotoxicity 2Vomiting 1Uveal Melanoma 1Thrombosis 1Substance Withdrawal Syndrome 1Retinal Diseases 1Reperfusion Injury 1Pain, Postoperative 1Opioid-Related Disorders 1Nausea 1Melanoma 1Macular Degeneration 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Choroid Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × salicylhydroxamic acid × Clear all
NCT03166813 2022-06-08

Remote Ischaemic Preconditioning in Childhood Cancer

The University of Hong Kong

Phase NA Completed
68 enrolled

Neoplasms, Myocardial Reperfusion Injury, Cardiotoxicity

NCT00621660 2008-02-22

Acupuncture Versus Sham for Radiotherapy-Induced Emesis

University Hospital, Linkoeping

Phase NA Completed
237 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡